Global Blood Glucose Monitoring Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Self-monitoring Devices(Blood glucose meter, Testing Strips, and Lancets), Continuous Blood Glucose Monitoring Devices(Sensors, Transmitter & Receiver, and Lancets).By Indication;
Diabetes Type I, Diabetes Type II, Gestational Diabetes.By End-use;
Hospitals, Home Care, and Diagnostic Centers.By Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Blood Glucose Monitoring Devices Market (USD Million), 2021 - 2031
In the year 2024, the Global Blood Glucose Monitoring Devices Market was valued at USD 16,645.87 million. The size of this market is expected to increase to USD 28,713.51 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.1%.
The global blood glucose monitoring devices market has experienced significant growth over the past decade, driven by the increasing prevalence of diabetes worldwide. Advances in technology have played a crucial role in enhancing the accuracy, convenience, and accessibility of these devices, which range from traditional blood glucose meters to continuous glucose monitoring (CGM) systems. The rise in diabetes cases, partly due to aging populations and lifestyle changes, has spurred demand for reliable and user-friendly monitoring solutions. Increased health awareness and the growing emphasis on proactive disease management have encouraged more individuals to adopt regular blood glucose monitoring as an integral part of their daily health regimen.
The market is witnessing a surge in innovative product developments and strategic collaborations among key players aimed at expanding their product portfolios and geographical reach. The integration of digital health technologies, such as mobile apps and cloud-based platforms, with blood glucose monitoring devices has further revolutionized diabetes management by enabling real-time data tracking and remote healthcare support. This trend is supported by favorable government initiatives and policies that promote the use of advanced medical devices to improve patient outcomes. As a result, the global blood glucose monitoring devices market is poised for continued expansion, with ongoing advancements and increasing adoption propelling it forward.
Global Blood Glucose Monitoring Devices Market Recent Developments
-
In March 2023, Abbott gained approval from the U.S. FDA to integrate its FreeStyle Libre 3 and FreeStyle Libre 2 continuous glucose monitoring (iCGM) system sensors with automated insulin delivery (AID) systems. Both sensors are currently available in the U.S. and approved for use in individuals aged four years and older.
-
In February 2023, Ascensia Diabetes Care Holdings AG, the developer of the CONTOUR BGM system portfolio, formed a global partnership with SNAQ, a mobile application offering nutritional insights for individuals managing diabetes.
-
In November 2021, Intuity Medical introduced the POGO automatic blood glucose monitoring system for diabetes patients in the U.S., aiming to enhance patients' quality of life.
Segment Analysis
The global blood glucose monitoring devices market is segmented by product into self-monitoring devices and continuous blood glucose monitoring (CGM) devices. Self-monitoring devices encompass blood glucose meters, testing strips, and lancets, which allow individuals to check their blood glucose levels at home or on the go, facilitating daily diabetes management. CGM devices include sensors, transmitters, receivers, and lancets, providing continuous and real-time monitoring of glucose levels. This advanced technology enables users to maintain better glycemic control by alerting them to fluctuations and trends in their glucose levels, thus preventing potential complications.
In terms of end-use, the market is divided into hospitals, home care, and diagnostic centers. Hospitals utilize these devices for accurate and timely glucose monitoring of patients, particularly in critical care settings. Home care represents a significant market segment, driven by the increasing prevalence of diabetes and the convenience of monitoring glucose levels without frequent hospital visits. Diagnostic centers also play a crucial role in early detection and ongoing management of diabetes through comprehensive glucose testing services. The market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. North America and Europe lead the market due to high diabetes prevalence, advanced healthcare infrastructure, and strong adoption of innovative technologies. However, the Asia Pacific region is anticipated to witness substantial growth due to rising healthcare awareness, increasing diabetes cases, and improving healthcare facilities.
Global Blood Glucose Monitoring Devices Segment Analysis
In this report, the Global Blood Glucose Monitoring Devices Market has been segmented by Product, Indication, End-use and Geography.
Global Blood Glucose Monitoring Devices Market, By Product
The Global Blood Glucose Monitoring Devices Market has been segmented by Product into Self-monitoring Devices and Continuous Blood Glucose Monitoring Devices.
Self-monitoring devices include blood glucose meters, testing strips, and lancets. Blood glucose meters are portable electronic devices that measure glucose levels in a small drop of blood, typically drawn using a lancet. Testing strips are the consumable part of the device onto which the blood sample is applied. Lancets are small, sharp needles used to prick the skin to obtain the blood sample. These devices are crucial for diabetes management, allowing individuals to monitor their blood sugar levels regularly and make informed decisions about their diet, exercise, and medication. The demand for these devices is driven by the increasing prevalence of diabetes, rising awareness about the importance of blood glucose monitoring, and technological advancements that enhance the accuracy and ease of use of these devices.
Continuous blood glucose monitoring (CGM) devices, on the other hand, represent a more advanced technology in diabetes care. CGM systems typically consist of sensors, a transmitter, and a receiver. The sensor is inserted under the skin and continuously measures glucose levels in the interstitial fluid. The transmitter sends this data to a receiver or a smartphone app, providing real-time glucose readings and trends. Some CGM systems can also send alerts to warn users of impending hypo- or hyperglycemia. These devices are particularly beneficial for individuals with Type 1 diabetes or those with Type 2 diabetes who require intensive insulin therapy. The market growth for CGM devices is fueled by their ability to provide more comprehensive glucose monitoring, which can lead to better glycemic control and reduced risk of diabetes-related complications. Innovations such as longer sensor life, integration with insulin pumps, and improved accuracy are making CGM devices more appealing to both patients and healthcare providers.
Global Blood Glucose Monitoring Devices Market, By Indication
The Global Blood Glucose Monitoring Devices Market has been segmented by Indication into Diabetes Type I, Diabetes Type II, Gestational Diabetes.
The global blood glucose monitoring devices market is segmented by indication into three primary categories: Diabetes Type I, Diabetes Type II, and Gestational Diabetes. Diabetes Type I, characterized by the body's inability to produce insulin, typically requires continuous blood glucose monitoring due to the reliance on external insulin sources. Devices targeting this segment focus on real-time monitoring solutions, offering precision and ease of use for patients managing their condition daily.
Diabetes Type II is the most common form of diabetes, involving insulin resistance or insufficient insulin production. This segment drives a significant share of the market, given the growing global prevalence of lifestyle-related factors such as obesity and sedentary behavior. Devices for Type II diabetes often prioritize convenience and integration with digital health tools, making it easier for patients to monitor their glucose levels and adjust their treatment plans accordingly.
Gestational diabetes, a temporary condition occurring during pregnancy, is another crucial segment. It requires careful monitoring to prevent complications for both the mother and the baby. Blood glucose monitoring devices for this indication are designed to be user-friendly, ensuring expectant mothers can track their glucose levels consistently and maintain a healthy pregnancy. The rising awareness of gestational diabetes and the importance of early diagnosis are contributing to increased demand in this market segment.
Global Blood Glucose Monitoring Devices Market, By End-use
The Global Blood Glucose Monitoring Devices Market has been segmented by End-use into Hospitals, Home Care and Diagnostic Centers.
Hospitals represent a significant share of the market due to the increasing prevalence of diabetes and the necessity for regular and accurate blood glucose monitoring in inpatient settings. In hospitals, blood glucose monitoring devices are critical for managing patients with both Type 1 and Type 2 diabetes, as well as those with gestational diabetes. These devices help in monitoring patients' glucose levels continuously, ensuring timely intervention and proper management of blood glucose levels to prevent complications such as hypoglycemia or hyperglycemia. The advanced technological features of these devices, such as real-time data tracking and integration with hospital information systems, enhance patient care and clinical outcomes.
Home care represents a growing segment of the market, driven by the increasing preference for personal health management and the rise in diabetic patients managing their condition outside of traditional healthcare settings. Home blood glucose monitoring devices offer convenience, allowing individuals to monitor their glucose levels regularly without the need for frequent hospital visits. This is particularly beneficial for elderly patients or those with mobility issues. The ease of use, affordability, and advancements in portable, user-friendly devices have significantly contributed to the expansion of this segment. The integration of mobile health applications and telemedicine services with these devices has empowered patients to track their health data and communicate with healthcare providers remotely, thereby enhancing disease management and quality of life. Diagnostic centers also play a crucial role in the market, providing specialized testing and monitoring services that support accurate diagnosis and ongoing management of diabetes.
Global Blood Glucose Monitoring Devices Market, By Geography
In this report, the Global Blood Glucose Monitoring Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Blood Glucose Monitoring Devices Market Share (%), by Geographical Region, 2024
North America, for instance, holds a significant share of the market due to the high prevalence of diabetes, advanced healthcare infrastructure, and strong adoption of innovative medical technologies. Europe follows closely, supported by similar factors, along with robust government initiatives aimed at managing diabetes and its complications. The Asia Pacific region is poised for rapid growth in the blood glucose monitoring devices market, driven by a large diabetic population, increasing healthcare awareness, and improving economic conditions.
Countries like China and India are particularly significant contributors to this growth, given their large populations and rising incidence of diabetes. The Middle East and Africa, while currently holding a smaller market share, are expected to see steady growth due to improving healthcare facilities and rising awareness about diabetes management. Latin America is also emerging as a notable market, with countries like Brazil and Mexico leading the way due to increasing healthcare expenditure and growing awareness about the importance of regular blood glucose monitoring.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Blood Glucose Monitoring Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Increase in sedentary lifestyles
- Rising obesity rates
- Demand for minimally invasive devices
-
Enhanced diagnostic accuracy - Innovations in monitoring technologies have led to devices capable of providing more precise and reliable measurements of blood glucose levels. These advancements empower individuals with diabetes to better manage their condition by making informed decisions about their diet, medication, and lifestyle choices.
With more accurate readings, patients can take timely actions to prevent hyperglycemia or hypoglycemia, thus reducing the risk of diabetes-related complications. Healthcare professionals can rely on these devices for more accurate assessments of patients' glucose levels, enabling them to tailor treatment plans more effectively and optimize patient outcomes.
Restraints:
- Resistance to new technologies
- Strict regulatory requirements
-
Risk of device-related infections - Despite the benefits they offer, blood glucose monitoring devices also pose certain risks, including the potential for device-related infections. Prolonged use of monitoring equipment, particularly if not properly maintained or sanitized, can increase the risk of infections at the site of insertion. This risk is particularly pertinent in continuous glucose monitoring systems where sensors are worn for extended periods.
To mitigate this risk, manufacturers are increasingly focusing on designing devices with features that minimize the risk of infection, such as materials that reduce skin irritation and improved insertion mechanisms that minimize tissue trauma. Healthcare providers play a crucial role in educating patients on proper device hygiene and maintenance practices to reduce the likelihood of infections.
Opportunities:
- Opportunities in wearable technology
- Expansion of home healthcare services
- Promotion of diabetes education programs
-
Expansion of e-commerce platforms - The expansion of e-commerce platforms has emerged as a significant trend shaping the Global Blood Glucose Monitoring Devices Market. With the increasing digitization of healthcare and growing consumer preference for online shopping, manufacturers are leveraging e-commerce channels to reach a wider audience and improve accessibility to their products. E-commerce platforms offer convenience, allowing patients to purchase monitoring devices and supplies from the comfort of their homes and have them delivered directly to their doorstep.
This trend is particularly beneficial for individuals living in remote areas or those with mobility limitations who may face challenges accessing traditional brick-and-mortar stores. The proliferation of e-commerce platforms enables manufacturers to provide comprehensive information about their products, facilitate easy comparison shopping, and offer personalized recommendations, enhancing the overall customer experience and driving market growth.
Competitive Landscape Analysis
Key players in Global Blood Glucose Monitoring Devices Market include:
- Medtronic plc
- F. Hoffmann-La Roche Ltd
- Bayer AG
- Lifescan, Inc.
- B. Braun Melsungen AG,
- Dexcom, Inc.
- Sanofi
- Abbott Laboratories
- Ascensia Diabetes Care Holdings AG
- Intuity Medical
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Indication
- Market Snapshot, By End-use
- Market Snapshot, By Region
- Global Blood Glucose Monitoring Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increase in sedentary lifestyles
- Rising obesity rates
- Demand for minimally invasive devices
- Enhanced diagnostic accuracy
- Restraints
- Resistance to new technologies
- Strict regulatory requirements
- Risk of device-related infections
- Opportunities
- Opportunities in wearable technology
- Expansion of home healthcare services
- Promotion of diabetes education programs
- Expansion of e-commerce platforms
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Blood Glucose Monitoring Devices Market, By Product, 2021 - 2031 (USD Million)
- Self-monitoring Devices
- Lancets
- Testing Strips
- Blood Glucose Meter
- Continuous Blood Glucose monitoring devices
- Sensors
- Transmitter & Receiver
- Lancets
- Self-monitoring Devices
- Global Blood Glucose Monitoring Devices Market, By Indication, 2021 - 2031 (USD Million)
- Diabetes Type I
- Diabetes Type II
- Gestational Diabetes
- Global Blood Glucose Monitoring Devices Market, By End-use, 2021 - 2031 (USD Million)
- Hospitals
- Home Care
- Diagnostic Centers
- Global Blood Glucose Monitoring Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Blood Glucose Monitoring Devices Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape Analysis
- Company Profiles
- Medtronic plc
- F. Hoffmann-La Roche Ltd
- Bayer AG
- Lifescan, Inc.
- B. Braun Melsungen AG,
- Dexcom, Inc.
- Sanofi
- Abbott Laboratories
- Ascensia Diabetes Care Holdings AG
- Intuity Medical
- Company Profiles
- Analyst Views
- Future Outlook of the Market